Optimal Use of Vaccines for Control of Influenza A Virus in Swine

Vaccines
Matthew R SandbulteJames A Roth

Abstract

Influenza A virus in swine (IAV-S) is one of the most important infectious disease agents of swine in North America. In addition to the economic burden of IAV-S to the swine industry, the zoonotic potential of IAV-S sometimes leads to serious public health concerns. Adjuvanted, inactivated vaccines have been licensed in the United States for over 20 years, and there is also widespread usage of autogenous/custom IAV-S vaccines. Vaccination induces neutralizing antibodies and protection against infection with very similar strains. However, IAV-S strains are so diverse and prone to mutation that these vaccines often have disappointing efficacy in the field. This scientific review was developed to help veterinarians and others to identify the best available IAV-S vaccine for a particular infected herd. We describe key principles of IAV-S structure and replication, protective immunity, currently available vaccines, and vaccine technologies that show promise for the future. We discuss strategies to optimize the use of available IAV-S vaccines, based on information gathered from modern diagnostics and surveillance programs. Improvements in IAV-S immunization strategies, in both the short term and long term, will benefit swine health a...Continue Reading

References

Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E D KilbourneB Grajower
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B E JohanssonE D Kilbourne
Feb 1, 1968·Journal of Virology·E D KilbourneR G Webster
Jul 7, 1983·The New England Journal of Medicine·A J McMichaelP A Beare
Feb 1, 1995·Veterinary Microbiology·B W LeeM E Larson
Apr 1, 1997·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·L L VincentP G Halbur
Feb 12, 1998·The Journal of Experimental Medicine·M B Graham, T J Braciale
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·K J FlynnP C Doherty
May 9, 2000·Veterinary Microbiology·N N ZhouR G Webster
May 9, 2000·Veterinary Microbiology·D L LarsenC W Olsen
May 10, 2000·Proceedings of the National Academy of Sciences of the United States of America·E HoffmannR G Webster
Jun 3, 2000·Annual Review of Immunology·P C Doherty, J P Christensen
Aug 23, 2000·Journal of Virology·R J WebbyR G Webster
Mar 13, 2001·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·S L SwensonJ K McMillen
Sep 15, 2001·Veterinary Immunology and Immunopathology·P P HeinenA T Bianchi
Sep 5, 2002·Reviews in Medical Virology·Jonathan O RaynerKurt I Kamrud
Aug 15, 2003·The Journal of General Virology·Ann H Reid, Jeffery K Taubenberger
Jan 28, 2004·The Journal of Infectious Diseases·Edwin D KilbourneJames T Matthews
Feb 21, 2004·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Dana SkibbeBruce H Janke
Mar 19, 2004·American Journal of Veterinary Research·Young K ChoiHan S Joo
Oct 28, 2004·Journal of Virology·Mikhail N MatrosovichHans-Dieter Klenk

❮ Previous
Next ❯

Citations

May 22, 2016·Vaccine·Bahar RamezanpourJeroen Kortekaas
Jun 9, 2016·Tierärztliche Praxis. Ausgabe G, Grosstiere/Nutztiere·Christine UnterwegerIsabel Hennig-Pauka
May 6, 2017·Viruses·Elma Tchilian, Barbara Holzer
Jun 15, 2017·Human Vaccines & Immunotherapeutics·Ingrid KarlssonAnders Fomsgaard
Dec 28, 2017·International Journal of Molecular Sciences·Guan YangJohn P Driver
Oct 21, 2017·Influenza and Other Respiratory Viruses·Andres H GutiérrezAnne S De Groot
Aug 12, 2016·Journal of Virology·Stephanie C TalkerWilhelm Gerner
Feb 13, 2016·Clinical and Experimental Vaccine Research·Hyunil KimKi Myung Choi
Sep 15, 2018·Influenza and Other Respiratory Viruses·Marcus J BoltonAmy L Vincent
Apr 7, 2018·Influenza and Other Respiratory Viruses·Rasna R WaliaAmy L Vincent
Oct 31, 2019·The Journal of Infectious Diseases·Robert L Atmar, Wendy A Keitel
Jul 12, 2020·Transboundary and Emerging Diseases·Fabian O Chamba PardoMontserrat Torremorell
Feb 7, 2019·Frontiers in Veterinary Science·Daniela S RajaoDaniel R Perez
Feb 26, 2019·Frontiers in Immunology·Barbara HolzerElma Tchilian
Feb 8, 2019·Emerging Infectious Diseases·Martha I NelsonMarie R Culhane
Feb 23, 2018·Frontiers in Microbiology·Daniela S Rajão, Daniel R Pérez
Mar 13, 2020·Scientific Reports·Rodrigo TapiaVíctor Neira
Nov 7, 2019·Veterinary Research·Santosh Dhakal, Gourapura J Renukaradhya
Jan 6, 2021·Porcine Health Management·Tanja OpriessnigPatrick G Halbur
Nov 17, 2020·Frontiers in Veterinary Science·José Carlos Mancera GraciaMonica Balasch
Jan 21, 2021·Preventive Veterinary Medicine·Jorge Garrido-MantillaMontserrat Torremorell
Feb 12, 2021·Viruses·Anders Fomsgaard, Margaret A Liu
Mar 2, 2021·Veterinary World·Ekaterina Romanovna VasilevskayaAngelina Igorevna Fokina
Mar 3, 2021·Porcine Health Management·Hamish A Salvesen, C Bruce A Whitelaw
Dec 8, 2016·Veterinary Microbiology·Amy L VincentNicola S Lewis
Nov 27, 2019·Veterinary Microbiology·Heather VinsonSheela Ramamoorthy
Mar 1, 2017·Veterinary Immunology and Immunopathology·Zahra F OlsonCrystal L Loving
May 18, 2021·One Health·Thomas C MooreKristen Pogreba-Brown
Mar 8, 2017·Research in Veterinary Science·Jirapat ArunoratRoongroje Thanawongnuwech
Sep 2, 2020·Developmental and Comparative Immunology·Weihong GuJohn P Driver

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
Enzyme-Linked Immunosorbent
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.